The intrigues among Blue Star countries made Zheng Li realize that it was impossible for them to work together as a team.
Even the cooperation between China and Russia has reservations.
The shortcut originally left by Zheng Li in the magic forum was for everyone to cooperate to purchase technical information and then share it.
I just didn’t expect that even in the face of such a huge temptation, the Blue Star countries would not be able to reach cooperation.
If cooperation doesn't work, there will only be competition.
Zheng Li realized that only by appropriately increasing the intensity of competition and limiting the scope of competition to the field of scientific research could the potential of Blue Star Civilization be better unleashed.
Cooperation is a bit illusory for the Blue Star civilization where war is an eternal theme.
This may be the nature of intelligent life. Mages also fought constantly in ancient and medieval times.
Li Wanqing said excitedly: "As long as you agree, I will definitely be able to convince them. Speaking of biological storage servers, we can put all 1000pb data on one storage server."
"The subsequent data processing speed can also increase a lot, which is of great benefit to us in processing brain nerve signals."
The development of brain-computer connection mobile phones for Blue Star's mainstream language systems has been completed.
As for brain-computer connected VR, currently the Chinese and English departments have mainly completed research and development, and other language departments will start research and development according to their market size.
Zheng Li asked: "What are the test data from Jiangcheng's brain-computer connection prosthetic arm?"
Li Wanqing: "The test data is very good. Currently, all testers have no accidents caused by errors in recognizing brain nerve signals."
"But the clinical trial of artificial limbs in the English department has been transferred from Americen to South Africa, and American has never approved our clinical trial application."
"The Chinese-language brain-computer-connected prosthetics are ready to be applied for production."
Kechuang Biotech's brain-computer connection technology is non-invasive, so the marketing approval process for medical devices will be faster.
Zheng ideally thinks that a lot of manpower in the R&D centers of Kechuang Biotech in Jiangcheng and Suzhou is devoted to the research and development of innovative drugs.
He asked: "How is the development progress of innovative drugs? Has any one started clinical trials?"
It is true that the research and development of innovative drugs is difficult, but science and technology research and development in this field have been started since its establishment in 19 years.
It's just that Zheng Li himself made relatively little contribution in this area. According to the normal timeline, the research and development of innovative drugs will take ten years to achieve certain results.
From early research to determining the chemical composition of a new drug, it takes roughly 3 to 6 years, and preclinical research takes 1 to 2 years.
After this long process, there are clinical studies and drug approvals.
Domestic pharmaceutical companies generally start with generic drugs, and it is extremely rare to start with directly innovative drugs like Kechuang Biotech.
He is a typical example of someone who is not short of money.
Li Wanqing replied: "We are still in the screening process of compounds and there haven't been many changes."
As the director of the Lion City R&D Center, Li Wanqing went back to Suzhou to attend the annual meeting of Science and Technology Innovation and got to know some researchers from other R&D centers.
Whether judging from internal company forums or private circles of friends and chats among researchers, Kechuang Biotech has not made much progress in the research and development of innovative drugs.
Among the major sectors of Kechuang Biotech, the fields of brain-computer connection and endorphins are the main sources of profits.
In the field of innovative drugs, we only see the input but not the output. Executives are biomedical industry insiders and know this is normal.
However, the relevant person in charge will be anxious. With such a large investment and no output, their voice and status within the company must not be high.
If there is any breakthrough progress in research and development, whether it improves its influence or attracts more attention and support, it will definitely be widely publicized.
Li Wanqing hasn't heard any sound so far. His colleagues in the entire innovative drug line seemed to have turned on silent mode. He knew that there was obviously no breakthrough progress.
This part of the weekly work summary for Zheng Li will definitely be included, but since there is no progress in innovative drugs, it can only occupy one sentence at most in the work report.
Zheng Li didn't know much about the real situation of innovative drugs.
After listening to Li Wanqing's answer, he said: "Innovative drugs do require relatively large investments and are long-term investments."
"The endorphins I made back then were not considered innovative drugs, they were generic drugs."
Li Wanqing flattered: "Endorphins were discovered by scientists last century, but no one has developed a manufacturing method, let alone a method for mass production."
"The difficulty of your research results is not lower than that of any innovative drug."
After Endorphin is launched on the market, the revenue and profits of this drug are as good as those of any multinational pharmaceutical giant's flagship product.
It can be said that it is the foundation of science and technology.
As for innovative drugs, even if billions of dollars are invested, it may not be possible to develop the next hit product with similar effects.
Take Pfizer as an example. Before sildenafil came out, there was a big gap between it and Merck in terms of revenue and profits.
After the release of sildenafil, Pfizer quickly surpassed Merck with this drug alone. Of course, MSD has come back in the past two years.
But sildenafil takes Pfizer straight up a notch.
Of course, Sci-Tech and Pfizer are different. Since the launch of brain-computer connected mobile phones, the outside world has regarded Kechuang Biotechnology as a diversified enterprise, not limited to the biomedical field.
Zheng Li rationalized his thoughts. His hope for Science and Technology Biotech was to expand its scale, improve its research and development capabilities, and be able to implement his research and development ideas in place when necessary.
Science and Technology Biotechnology is still in the development stage now. After it stabilizes, Zheng Li plans to inspect internal researchers and keep those with the highest capabilities.
...
After Huawei's biological storage server became popular, the outside world was discussing it, and the discussion in the industry became even more heated.
Especially Sugon, Inspur, Unisplendour, and Yangtze River Storage. They are all companies in the industry, and Huawei suddenly launched satellites.
Why haven't I heard anything before?
Yangtze Storage is a little better. After all, its vice president suddenly went to work for a state-owned enterprise called Deep Blue Storage.
They had guessed what big changes would happen in the domestic storage industry.
But they didn't expect that this movement was a bit beyond their imagination. I have never heard of any domestic R&D team with mature technology in biostorage.
The outside world will focus on Huawei, but the industry knows that Huawei cannot develop biological storage technology on its own.
It's not that they look down on Huawei, they admire Huawei's R&D capabilities, but it's that Huawei has no relevant technical reserves before, and it is completely unreasonable to pull out biological storage out of thin air.
Everyone’s attention naturally focused on the dark blue storage mentioned at the Huawei press conference.
The investigation did not reveal any reason, except that Guan Yang of Yangtze River Storage went there to become the chairman.
Executives of these companies in the industry are also asking around to find out which teams in domestic universities or research institutes that are engaged in DNA macromolecule storage have been poached.
There is also no news that any of the professors who have previously published papers related to DNA storage have resigned recently.
As Guan Yang had expected, after Huawei's press conference, there was no need for him to do door-to-door marketing. The heads of various companies came to visit one after another.
"Brother Guan, you are so ridiculous. With such advanced technology in biological storage, you didn't inform Sugon first. Sugon also has deep technical accumulation and rich experience in the field of storage servers."
As soon as the chairman of Inspur left, the chairman of Shuguang came to the door. Li Jun did not beat around the bush and got straight to the point.
Shuguang is also a state-owned enterprise, but it is not directly managed by the central government. It is an enterprise incubated by the Ministry of Science and Technology and the Chinese Academy of Sciences. The current actual controller is the Institute of Computing Technology of the Chinese Academy of Sciences.
When Guan Yang was the vice president of Yangtze River Storage, he was more than one level behind Li Jun.
Guan Yang smiled and said: "The main reason is that our technology has just been developed and is not mature enough. There are still many areas that need improvement, so we are not embarrassed to cooperate with Sugon."
"When I was at Yangtze Storage, I was unable to cooperate with Sugon because the technology was not mature enough. This time when I came to Deep Blue Storage, the main technology was still not mature enough."
What Guan Yang was alluding to was that Yangtze Storage had previously hoped to break into Sugon's supply chain system, but Sugon had been holding back on the grounds that Yangtze Storage's technology was not mature enough.
The supplier of Sugon storage servers has always been Amerikan's Seagate. Seagate is the world's largest hard drive and disk manufacturer.
Technically, Seagate is definitely more mature.
However, Yangtze Storage is a key national support project, and Yangtze Storage’s goal at the time was not to directly replace Seagate, but to enter Sugon’s supply chain system and only supply goods if conditions were met.
Even with such conditions, Shuguang did not agree.
Li Jun knew that Guan Yang was still worried about that incident. He explained: "At that time, we hoped to choose Yangtze Storage, but because we signed a three-year strategic cooperation agreement with Seagate in 2018."
"In addition, Yangtze Memory's 64-layer flash memory technology was not yet mature at the time. We did not expect that Yangtze Memory's technology would advance so quickly."
"In just two years, we have conquered 128-layer 3D NAND technology."
Li Jun is just making excuses. The strategic cooperation agreement is not an exclusive agreement. Yangtze Storage's 64-layer flash memory technology can be used in Sugon's low-end storage server models.
Guan Yang did not expose the other party. He was just looking for excuses to prevaricate the other party. He had already changed companies. It was impossible for him to embarrass Li Jun because of some irregularities of Yangtze River Storage.
Guan Yang only realized in the past few days why he was appointed as the chairman of Deep Blue Storage. It was because he had wide enough connections and was specially sent to reject these requests.
"Understand, after the biological storage technology matures, we will authorize all Chinese companies."
"You don't have to worry."
"We are all state-owned enterprises. How could our technology not be licensed to Sugon?"
